Gadopentetate Dimeglumine Injection/API
Since Gadopentetate DimeglumineInjection was launched in 1992 by BeiluPharma in China, it was highly recommended and accepted by the radiologist, and quickly occupied the market with its excellent quality and reasonable price. Up to now, linear gadolinium has been safely used for nearly 30 years, with excellent enhancement effects and few side effects. Beilu also produces gadobutrol injection with high quality and reasonable price, contact us for more info!
Product name: Gadopentetate Dimeglumine Injection
Generic name: Gadopentetate Dimeglumine Injection
Type: Injectable Contrast Media for MRI, Linear Contrast Media
Ingredients: Gadopentetate Dimeglumine
Specification: 10ml:4.69 g; 12ml:5.63 g; 15ml:7.04 g; 20ml:9.38 g
Posology and method of administration: Intravenous injection
Adverse reactions: See the details from the package insert
Shelf life: 36 months
MRI Contrast Media-Gadopentetate Dimeglumine Injection/API
MRI Contrast Media-Gadopentetate Dimeglumine Injection/API
Indication of Gadopentetate Dimeglumine Injection
Magnetic resonance imaging of the central nervous system (brain and spinal cord), abdomen, chest, pelvis, limbs and other human organs and tissues.
Precautions of Gadopentetate Dimeglumine Injection
Current evidence shows that after repeated use of GBCAs, trace amounts of gadolinium can remain in the brain and other body tissues. Research reports have shown that multiple uses of GBCAs can increase the intensity of brain signals, especially in the dentate nucleus and globus pallidus. Currently, there are more reports about linear GBCAs and fewer reports about macrocyclic GBCAs. Animal experiments have shown that the amount of gadolinium deposited after repeated use of linear GBCAs is higher than that of repeated use of macrocyclic.
The clinical significance of brain gadolinium deposition is unclear.
In order to minimize the potential risks associated with gadolinium deposition in the brain, it must be used in strict accordance with the indications and approved doses. It is recommended to use the lowest approved dose that meets the requirement of diagnosis and perform a careful benefit-risk assessment and patient informed communication before repeated administration.
There are many contrast media manufacturing companies, but we are one of the best choices for you.
在线联系供应商
Other supplier products
 |
Gadopentetate Dimeglumine Injection/API | Since Gadopentetate Dimeglumine Injectionwas launched in 1992 by Beilu Pharma in China, it was highly recommended and accepted by the radiologist, ... |
 |
Glimepiride Tablets | Glimepiride Tablets is a sulfonylurea hypoglycemic drug that can be used in combination with insulin. In 2001, Glimepiride tablets (Dibei), as the ... |
 |
Gadopentetate Dimeglumine Injection/API | Since Gadopentetate Dimeglumine Injectionwas launched in 1992 by Beilu Pharma in China, it was highly recommended and accepted by the radiologist, ... |
 |
Gadobutrol Injection/API | In 2020, Beilulaunched its macrocyclic Contrast Media- Gadobutrol Injection, it is gadolinium-based non-ionic Contrast Media, a paramagnetic Contra... |
 |
CT/X-Ray Contrast Media | CT/X-Ray Contrast Media The main component of CT/X-ray Contrast Media is iodine. The Iodinated Contrast Media is a colorless, transparent, slightl... |
